These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 11352498

  • 1. A novel and rapid prediction assay for the effectiveness of IL-6 receptor specific antisense oligonucleotides by proliferation inhibition of an interleukin-6 dependent cell line.
    Lia Varga V, Falus A, Pallinger E, Novák I, Fülöp KA, Toth S, Rose-John S.
    Cell Biol Int; 2001; 25(3):253-6. PubMed ID: 11352498
    [Abstract] [Full Text] [Related]

  • 2. gp130-specific antisense oligonucleotides inhibit IL-6 signal inducing junB mRNA transcription in the human hepatoma cell line, HepG2.
    Varga VL, Fülöp AK, Holub MC, Tóth S, Szalai C, Falus A.
    Cell Biol Int; 2001; 25(8):835-40. PubMed ID: 11482910
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
    Kong B, Isozaki T, Sasaki S.
    Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
    [Abstract] [Full Text] [Related]

  • 6. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P, Tóth S, Rose-John S, Madurka I, Fejér G, Szalai C, Falus A.
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Negative modulation of signal transduction via interleukin splice variation.
    Denessiouk KA, Denesyuk AI, Johnson MS.
    Proteins; 2008 May 01; 71(2):751-70. PubMed ID: 17979192
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J, Ohnesorge N, Rose-John S.
    Scand J Immunol; 2006 May 01; 63(5):321-9. PubMed ID: 16640655
    [Abstract] [Full Text] [Related]

  • 10. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF, Zhuang M, Zhu LJ, Sheng ZL, Zhu YQ, Li CP.
    Ai Zheng; 2004 Jun 01; 23(6):715-8. PubMed ID: 15191679
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC.
    Clin Cancer Res; 2005 Jun 01; 11(11):4251-8. PubMed ID: 15930364
    [Abstract] [Full Text] [Related]

  • 12. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 13. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T, Imaizumi T, Fujimoto K, Cui X, Shibata T, Tamo W, Kumagai M, Tanji K, Yoshida H, Kimura H, Satoh K.
    Exp Cell Res; 2001 Sep 10; 269(1):35-41. PubMed ID: 11525637
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V.
    J Surg Res; 2009 Dec 10; 157(2):235-42. PubMed ID: 19589542
    [Abstract] [Full Text] [Related]

  • 15. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
    Yoshida S, Harada T, Iwabe T, Taniguchi F, Mitsunari M, Yamauchi N, Deura I, Horie S, Terakawa N.
    Hum Reprod; 2004 Aug 10; 19(8):1821-5. PubMed ID: 15166129
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.
    Marta R, Goette N, Lev P, Heller P, Kornblihtt L, Vassallú P, Glembotsky A, Pirola C, Molinas F.
    Haematologica; 2004 Jun 10; 89(6):657-63. PubMed ID: 15194532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
    Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF.
    Int Immunol; 2007 Jun 10; 19(6):685-93. PubMed ID: 17496315
    [Abstract] [Full Text] [Related]

  • 19. The soluble IL-6 receptors: serum levels and biological function.
    Montero-Julian FA.
    Cell Mol Biol (Noisy-le-grand); 2001 Jun 10; 47(4):583-97. PubMed ID: 11502067
    [Abstract] [Full Text] [Related]

  • 20. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
    Linker RA, Lühder F, Kallen KJ, Lee DH, Engelhardt B, Rose-John S, Gold R.
    J Neuroimmunol; 2008 Dec 15; 205(1-2):64-72. PubMed ID: 18950871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.